Organisation › Details

Gilead Sciences (Group)

http://www.gilead.com

	Start	1987-06-22 established
	Industry	biopharmaceutical
	Industry 2	virostatic agent

	Street	333 Lakeside Drive
	City	94404 Foster City, CA
		Address record changed: 2015-04-24

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	4,230,045,000 (revenues, total, consolidated (2007) 2007-12-31)
	Profit	1,615,298,000 (2007-12-31)
	Cash	2,722,422,000 (2007-12-31)


		Record changed: 2019-04-15

More documents for Gilead Sciences (Group)

[1] Biocartis Group N.V.. (6/1/19). "Press Release: Biocartis and Kite Sign Agreement for Development of Assays Supporting Kite's Therapies". Mechelen....
[2] Galapagos N.V.. (5/29/19). "Press Release: Gilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019)". Foster City, CA & Mechelen....
[3] Hookipa Pharma Inc.. (5/8/19). "Press Release: Hookipa Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead". New York, NY & Vienna....
[4] Galapagos N.V.. (4/25/19). "Press Release: Galapagos Reports on Historic First Quarter 2019". Mechelen....
[5] Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsvaerd....
[6] Hookipa Pharma Inc.. (1/2/19). "Press Release: Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead". New York, NY & Vienna....
[7] Gilead Sciences, Inc.. (12/10/18). "Press Release: Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer". Foster City, CA....
[8] Aelix Therapeutics S.L.. (10/18/18). "Press Release: Aelix Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure"....
[9] Galapagos N.V.. (9/11/18). "Press Release: Gilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints in First Phase 3 Study in Rheumatoid Arthritis". Foster City, CA & Mechelen....
[10] Gilead Sciences, Inc.. (7/19/18). "Press Release: Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors". Santa Monica, CA & Utrecht....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top